Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49,633,071
-
Total 13F shares
-
31,766,131
-
Share change
-
+1,195,054
-
Total reported value
-
$403,725,355
-
Put/Call ratio
-
72%
-
Price per share
-
$12.71
-
Number of holders
-
128
-
Value change
-
-$100,224,441
-
Number of buys
-
76
-
Number of sells
-
68
Institutional Holders of PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) as of Q2 2019
As of 30 Jun 2019,
PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) was held by
128 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,766,131 shares.
The largest 10 holders included
STATE STREET CORP, VANGUARD GROUP INC, Partner Fund Management, L.P., Sarissa Capital Management LP, Palo Alto Investors LP, FRED ALGER MANAGEMENT INC, CITADEL ADVISORS LLC, MACQUARIE GROUP LTD, DEUTSCHE BANK AG\, and NORGES BANK.
This page lists
128
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.